Der Nephrologe

, Volume 5, Issue 2, pp 150–151

Induktionstherapie bei Lupusnephritis

Wirksamkeit von Mycophenolatmofetil
Für Sie gelesen
  • 58 Downloads

Induction therapy in lupus nephritis

Effects of mycophenolatmofetil

Literatur

  1. 1.
    Isenberg D, Appel GB, Contreras G et al (2010) Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 49:128–140CrossRefPubMedGoogle Scholar
  2. 2.
    Chan TM, Li FK, Tang CS et al (2000) Hong Kong-Guangzhou Nephrology Study Group. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343:1156–1162CrossRefPubMedGoogle Scholar
  3. 3.
    Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219–2228CrossRefPubMedGoogle Scholar
  4. 4.
    Sinclair A, Appel G, Solomons N et al (2007) Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS). Lupus 16:972CrossRefPubMedGoogle Scholar
  5. 5.
    Appel GB, Contreras G, Dooley MA et al (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20:1103–1112CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Medizinische Klinik, Abteilung für NephrologieKlinikum Rechts der Isar, Technische Universität MünchenMünchenDeutschland

Personalised recommendations